GlassScriptPhysician profile
Peter L Mcganity
NPI 1124022694
$2,785.90
in general payments reported to CMS, 2019-2025
12 companies · $359 in 2025
The $359 reported for 2025 was less than what a typical Orthopaedic Surgery provider received nationally (typical 2025 total: $569).
Payments by year
General payments by program year, as reported to CMS.
General payments by year: 2021: $523 · 2022: $703 · 2023: $653 · 2024: $547 · 2025: $359.
What the payments were for
Nature of payment as categorized by the reporting companies: meals, consulting, travel, and so on.
Food and Beverage: $1,560.
View as a table
| Payment type | Amount (2023-2025) |
|---|---|
| Food and Beverage | $1,560.12 |
Payment-type detail covers 2023-2025; earlier years are included in totals but not broken out here.
Who reported paying
General payments only, as reported to CMS. Product names cover 2023-2025.
| Company | General payments | Years | Top products |
|---|---|---|---|
| Depuy Synthes Sales INC. | $721.12 | 2022-2025 | Na, Va-Lcp |
| Mission Medical Distribution, LLC | $410.40 | 2023-2025 | |
| Zimmer Biomet Holdings, INC. | $274.50 | 2021-2025 | Persona |
| Si-Bone, INC. | $253.30 | 2021-2022 | |
| Stryker Corporation | $172.07 | 2023 | Augment Injectable |
| Sanara Medtech INC. | $164.37 | 2024 | Celleraterx |
| Medline Industries LP | $156.68 | 2022 | |
| Globus Medical, INC. | $149.59 | 2022 | |
| Bone Support INC. | $137.90 | 2021 | |
| Vericel Corporation | $121.91 | 2021 | |
| Wishbone Medical INC. | $118.31 | 2023 | |
| Kci USA, INC. | $105.75 | 2023 | Prevena, V.A.C.Ulta |
Drugs and devices associated with these payments
CMS records which products a payment was associated with, not how the money was allocated. Association is not allocation: one payment can be associated with several products, and a product listing does not mean the payment was made because of that product. Product detail covers 2023-2025.
If you want to bring it up
Most clinicians are glad to talk about this. A respectful way in:
- "I saw Peter Mcganity listed in the CMS Open Payments database. Can you tell me about your work with those companies?"
- "Is there a generic or alternative to this medication, and would it work as well for me?"
- "What made you choose this particular treatment for my situation?"
These are normal questions. A good clinician will welcome them.
Share this page
Keep an eye on this page
Get an email when the next June refresh changes this page. No account needed.
Source: CMS Open Payments, program years 2019-2025, as reported to CMS by drug and device makers (published June 30, 2026). Drug and device detail covers 2023-2025.